Increased Prevalence of Depressive Symptoms in Patients Undergoing Revision for Periprosthetic Joint Infection

Vishal Hegde, MD; Daniel N. Bracey, MD, PhD; Roseann M. Johnson, BS, CCRP; Douglas A. Dennis, MD; Jason M. Jennings, MD, DPT

Arthroplasty Today (Feb 2022)

Increased Prevalence of Depressive Symptoms in Patients Undergoing Revision for Periprosthetic Joint Infection

Vishal Hegde, MD,
Daniel N. Bracey, MD, PhD,
Roseann M. Johnson, BS, CCRP,
Douglas A. Dennis, MD,
Jason M. Jennings, MD, DPT

Affiliations

Vishal Hegde, MD: Colorado Joint Replacement, Denver, CO, USA; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA
Daniel N. Bracey, MD, PhD: Colorado Joint Replacement, Denver, CO, USA; Department of Orthopaedic Surgery, University of North Carolina, Chapel Hill, NC, USA
Roseann M. Johnson, BS, CCRP: Colorado Joint Replacement, Denver, CO, USA
Douglas A. Dennis, MD: Colorado Joint Replacement, Denver, CO, USA; Department of Mechanical and Materials Engineering, University of Denver, Denver, CO, USA; Department of Orthopaedics, University of Colorado School of Medicine, Denver, CO, USA; Department of Biomedical Engineering, University of Tennessee, Knoxville, TN, USA; Corresponding author. 2535 S Downing St. Suite 100, Denver, CO 80210. Tel.: 303-260-2940.
Jason M. Jennings, MD, DPT: Colorado Joint Replacement, Denver, CO, USA; Department of Mechanical and Materials Engineering, University of Denver, Denver, CO, USA

Journal volume & issue: Vol. 13
pp. 69 – 75

Abstract

Read online

Background: Periprosthetic joint infection (PJI) is a devastating complication after total joint arthroplasty. Patients undergoing revision for PJI may experience psychological distress and symptoms of depression, both of which are linked to poor postoperative outcomes. We, therefore, aim to identify the prevalence of depression and depressive symptoms in patients before treatment for PJI and their link to functional outcomes. Methods: Patients undergoing either debridement with implant retention (DAIR) or 2-stage exchange for PJI with minimum 1-year follow-up were retrospectively reviewed. The 2-stage (n = 37) and single-stage (n = 39) patients that met inclusion criteria were matched based off age (±5 years), gender, and body mass index (±5) to patients undergoing aseptic revisions. Outcomes evaluated included a preoperative diagnosis of clinical depression and preoperative and postoperative Veterans RAND 12 Item Health Survey mental component score and physical component score. Results: Compared to matched controls, the prevalence of depressive symptoms was significantly greater in patients undergoing 2-stage exchange preoperatively (40.5% vs 10.8%, P < .01) but not postoperatively (21.6% vs 10.8%, P = .20). Patients undergoing DAIR with either preoperative depressive symptoms (31.3 vs 40.9, P = .05) or a preoperative diagnosis of depression (27.7 vs 43.1, P < .01) had significantly lower physical component scores postoperatively. Conclusions: Patients undergoing 2-stage exchange for PJI have a four times higher prevalence of preoperative depressive symptoms than patients undergoing aseptic revision. Patients undergoing DAIR with depression or preoperative depressive symptoms have lower functional scores postoperatively. Orthopedic surgeon screening of PJI patients with referral for treatment of depression may help improve outcomes postoperatively.

Published in Arthroplasty Today

ISSN: 2352-3441 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Surgery: Orthopedic surgery
Website: https://www.journals.elsevier.com/arthroplasty-today/

About the journal

Abstract

Keywords